Page last updated: 2024-10-24

lymphocyte migration into lymph node

Definition

Target type: biologicalprocess

The movement of a lymphocyte within the lymphatic system into a lymph node, and its subsequent positioning within defined functional compartments such as sites of cell activation by antigen. [GOC:BHF, GOC:pr, PMID:18379575]

Lymphocyte migration into lymph nodes is a critical process in the adaptive immune response, facilitating the encounter of antigen-presenting cells (APCs) with lymphocytes and the initiation of an immune response. This journey involves several stages:

1. **Entry into the Lymph Node:** Lymphocytes enter the lymph node through specialized structures called **high endothelial venules (HEVs)**. These blood vessels have unique cuboidal endothelial cells that express adhesion molecules like **CD34, GlyCAM-1, and PNAd** which bind to **L-selectin** on the surface of lymphocytes. This interaction mediates the initial tethering and rolling of lymphocytes along the HEV wall.

2. **Chemokine-mediated Activation:** Once lymphocytes are rolling on the HEV surface, they encounter chemokines like **CCL21** and **CCL19**, which are secreted by stromal cells within the lymph node. These chemokines bind to **CCR7** receptors on lymphocytes, triggering a signaling cascade that leads to the activation of integrins, particularly **LFA-1**.

3. **Integrin-mediated Adhesion:** Activated LFA-1 on the lymphocyte surface binds to **ICAM-1** on the HEV endothelium, resulting in strong adhesion of the lymphocyte to the vessel wall. This firm adhesion is crucial for the lymphocyte to overcome the shear forces of blood flow and transmigrate through the HEV.

4. **Diapedesis:** The lymphocyte then undergoes diapedesis, a process where it squeezes between endothelial cells and enters the lymph node parenchyma. This process requires the coordinated action of cytoskeletal rearrangements and the involvement of other adhesion molecules like **PECAM-1 (CD31)**.

5. **Migration within the Lymph Node:** Once inside the lymph node, lymphocytes continue their journey towards the T cell zone or B cell zone depending on their type. This migration is guided by chemokine gradients and interactions with stromal cells and other lymphocytes. The chemokines CCL21 and CCL19, along with their receptors CCR7, play a crucial role in directing lymphocytes to their appropriate zones.

6. **Exit from the Lymph Node:** Lymphocytes that fail to encounter their specific antigen exit the lymph node through efferent lymphatic vessels. This ensures that only antigen-specific lymphocytes are retained within the lymph node for an extended period, promoting the development of an immune response.

The intricate process of lymphocyte migration into lymph nodes ensures the efficient delivery of lymphocytes to the site of antigen presentation, enabling the adaptive immune system to respond effectively to diverse pathogens and foreign substances.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Serine/threonine-protein kinase WNK1A serine/threonine-protein kinase WNK1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H4A3]Homo sapiens (human)
Alpha-(1,3)-fucosyltransferase 7An alpha-(1,3)-fucosyltransferase 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q11130]Homo sapiens (human)
C-C chemokine receptor type 7A C-C chemokine receptor type 7 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32248]Homo sapiens (human)

Compounds (14)

CompoundDefinitionClassesRoles
2,3-dihydroxybenzoic acid2,3-dihydroxybenzoic acid : A dihydroxybenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 3. It occurs naturally in Phyllanthus acidus and in the aquatic fern Salvinia molesta.

2,3-dihydroxybenzoic acid: RN given refers to parent cpd

dihydroxybenzoic acid : Any member of the class of hydroxybenzoic acids carrying two phenolic hydroxy groups on the benzene ring and its derivatives.
dihydroxybenzoic acidhuman xenobiotic metabolite;
plant metabolite
protocatechuic acid3,4-dihydroxybenzoic acid : A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 4.

protocatechuic acid: RN given refers to parent cpd; structure
catechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
gallic acidgallate : A trihydroxybenzoate that is the conjugate base of gallic acid.trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
beta-resorcylic acidbeta-resorcylic acid: RN given refers to parent cpd; structure
2,5-dihydroxybenzoic acid2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
dihydroxybenzoic acidEC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
fungal metabolite;
human metabolite;
MALDI matrix material;
mouse metabolite
veratric acid3,4-dimethoxybenzoic acid : A member of the class of benzoic acids that is benzoic acid substituted by methoxy groups at positions 2 and 3.

veratric acid: RN given refers to parent cpd; structure
benzoic acidsallergen;
plant metabolite
methyl gallatemethyl 3,4,5-trihydroxybenzoate : A gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties.

methyl gallate: has both immunosuppressive and phytogenic antineoplastic activities; isolated from Acer saccharinum
gallate esteranti-inflammatory agent;
antioxidant;
plant metabolite
3,4,5-trimethoxybenzoic acid3,4,5-trimethoxybenzoic acid : A benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents.

3,4,5-trimethoxybenzoic acid: RN given refers to parent cpd; structure
benzoic acids;
methoxybenzenes
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
syringic acidsyringic acid : A dimethoxybenzene that is 3,5-dimethyl ether derivative of gallic acid.

syringic acid: RN given refers to parent cpd; structure in third source
benzoic acids;
dimethoxybenzene;
phenols
plant metabolite
staurosporineindolocarbazole alkaloid;
organic heterooctacyclic compound
apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
tak 779
cenicriviroccenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH).

cenicriviroc: an inhibitor of HIV-1
aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide
anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
guanosine diphosphateGuanosine Diphosphate: A guanine nucleotide containing two phosphate groups esterified to the sugar moiety.guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor